Drreddys Laboratories reported $49.19B in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Ani Pharmaceuticals ANIP:US $ 48.62M 5.9M
Aphria Inc APH:CN C$ 153.64M 6.89M
Aurora Cannabis Inc ACB:CN 54.61M 555K
Bayer BAYN:GR € 10854M 1474M
Canopy Growth Corp WEED:CN C$ 136.21M 12.23M
Catalent CTLT:US $ 1188.2M 134.9M
Cipla CIPLA:IN IR 55043.5M 8979M
Corcept Therapeutics CORT:US $ 91.59M 12.15M
Drreddys Laboratories RDY:US $ 49194M 1910M
Endo International Ordinary Shares ENDP:US $ 713.83M 4.09M
GlaxoSmithKline GSK:LN 8092M 674M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Hikma Pharmaceutical HIK:LN 1.22B 7M
Horizon Pharma HZNP:US $ 832.55M 490.14M
JAZZ PHA JAZZ:US $ 751.81M 144.23M
Lannett LCI:US $ 106.01M 6.36M
Lonza Group LONN:SW 2.54B 1.11B
Novartis NOVN:VX SF 13294M 600M
Pacira Pharmaceuticals PCRX:US $ 135.59M 16.56M
Phibro Animal Health PAHC:US $ 220.28M 8.55M
Prestige Brands PBH:US $ 269.18M 31.42M
Richter Gedeon RICHT:HB 155.91B 15.02B
Sun Pharmaceuticals SUNP:IN IR 97187.4M 11957.6M
Supernus Pharmaceuticals SUPN:US $ 141.33M 10.4M
Teva Pharmaceutical TEVA:IT 3.91B 72M